Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations
- 31 December 2009
- journal article
- review article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 62 (12), 1268-1278
- https://doi.org/10.1016/j.jclinepi.2009.01.009
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- “Developing Good Taste in Evidence”: Facilitators of and Hindrances to Evidence‐Informed Health Policymaking in State GovernmentThe Milbank Quarterly, 2008
- Epidemiologic analysis of racial/ethnic disparities: Some fundamental issues and a cautionary exampleSocial Science & Medicine, 2008
- A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failureNature Medicine, 2008
- Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort studyBMJ, 2007
- Drug-Induced Epigenetic Changes Produce Drug TolerancePLoS Biology, 2007
- Racial Categories in Medical Practice: How Useful Are They?PLoS Medicine, 2007
- Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical JournalsJAMA, 2007
- Neighbourhood influences on healthJournal of Epidemiology and Community Health, 2007
- Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic reviewBMJ, 2006
- Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?PLoS Medicine, 2005